Abstract
To evaluate the possibility of left ventricular(LV)dysfunction in patients(pts) with cystic fibrosis(CF), we studied 80 ambulatory and hospitalized CF pts with a mean Shwachman-Kulczyki clinical score of 55(range 15-100)using standard pulmonary function tests, echocardiography (ECHO) and systolic time intervals (STI). ECHO measurements were made of LV internal dimensions at end-diastole(ED) and end-systole, LV posterior wall thickness(PWT) and septal thickness(ST). All values were indexed by body surface area. LV-ED volume (LVEDV) and LV ejection fraction(EF) were calculated. We observed an increase in PWT which was directly related to a decrease in clinical score(p<.0l) and mid-maximal expiratory flow rate (p< .05) and increased functional residual capacity (FRC)(p<.05). EF decreased significantly with increased FFC(p<.05). LV-EDV decreased with increased residual volume (RV)(p<.05) and total lung capacity(p<.05). When compared with age-corrected normal values, the ratio of the STI's, pre-ejection period and LV ejection time(PEP/LVET) increased with decreased clinical score(p<.05) and increased RV(p<.01) and FRC(p<.05). PEP/LVET also increased with increased PWT(p<.001), ST(p<.01) and indexed right ventricular dimension by ECHO(p<.001) and with decreased LVEDV(p<.05). These data showing increased PWT and PEP/LVET, and decreased EF suggest LV dysfunction with increasing severity of pulmonary involvement in pts with CF.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tucker, C., Johnson, D., Rosenthal, A. et al. LEFT VENTRICULAR DYSFUNCTION IN PATIENTS WITH CYSTIC FIBROSIS. Pediatr Res 8, 355 (1974). https://doi.org/10.1203/00006450-197404000-00090
Issue Date:
DOI: https://doi.org/10.1203/00006450-197404000-00090